Tamás Pivarcsik

Mr. Tamás Pivarcsik

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
TPTamás Pivarcsik
Tamás Pivarcsik
ODOrsolya Dömötör
Orsolya Dömötör
JMJános P. Mészáros
János P. Mészáros
NMNóra V. May
Nóra V. May
Gabriella SpenglerGabriella Spengler
Gabriella Spengler
EEEva Anna Enyedy
Eva Anna Enyedy
Solution chemical properties of two novel 8-hydroxyquinoline-D-proline and homo-proline hybrids were investigated along with their complex formation with [Rh(η5-C5Me5)(H2O)3]2+ and [Ru(η6-p-cymene)(H2O)3]2+ ions by pH-potentiometry, UV-visible spectrophotometry and 1H NMR spectroscopy. Due to the zwitterionic structure of the ligands, they possess excellent water solubility as well as their complexes. The complexes exhibit high solution stability in a wide pH range; no significant dissociation occurs at physiological pH. The hybrids and their Rh(η5-C5Me5) complexes displayed enhanced cytotoxicity in human colon adenocarcinoma cell lines and exhibited multidrug resistance selectivity. In addition, the Rh(η5-C5Me5) complexes showed increased selectivity to the chemosensitive cancer cells over the normal cells; meanwhile, the Ru(η6-p-cymene) complexes were inactive, most likely due to arene loss. Interaction of the complexes with human serum albumin (HSA) and calf-thymus DNA (ct-DNA) was investigated by capillary electrophoresis, fluorometry and circular dichroism. The complexes are able to bind strongly to HSA and ct-DNA, but DNA cleavage was not observed. Changing the five-membered proline ring to the six-membered homoproline resulted in increased lipophilicity and cytotoxicity of the Rh(η5-C5Me5) complexes while changing the configuration (L vs. D) rather has an impact on HSA or ct-DNA binding.

22 July 2021 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
ODOrsolya Dömötör
Orsolya Dömötör
TPTamás Pivarcsik
Tamás Pivarcsik
JMJános P. Mészáros
János P. Mészáros
István SzatmáriIstván Szatmári
István Szatmári
FFFerenc Fülöp
Ferenc Fülöp
EEEva Anna Enyedy
Eva Anna Enyedy
The binding affinity of Ru(η6-p-cymene) and Rh(η5-C5Me5) complexes of 8-hydroxyquinoline derivatives and oligopyridine ligands to albumin was studied by spectroscopic and separation techniques.

Verified
Journal Article
Open access
PDF file
TPTamás Pivarcsik
Tamás Pivarcsik
VPVivien Pósa
Vivien Pósa
HKHilda Kovács
Hilda Kovács
NMNóra V. May
Nóra V. May
Gabriella SpenglerGabriella Spengler
Gabriella Spengler
EEEva Anna Enyedy
Eva Anna Enyedy
Multidrug resistance (MDR) in cancer is one of the major obstacles of chemotherapy. We have recently identified a series of 8-hydroxyquinoline Mannich base derivatives with MDR-selective toxicity, however with limited solubility. In this work, a novel 5-nitro-8-hydroxyquinoline-proline hybrid and its Rh(η5-C5Me5) and Ru(η6-p-cymene) complexes with excellent aqueous solubility were developed, characterized, and tested against sensitive and MDR cells. Complex formation of the ligand with essential metal ions was also investigated using UV-visible, circular dichroism, 1H NMR (Zn(II)), and electron paramagnetic resonance (Cu(II)) spectroscopic methods. Formation of mono and bis complexes was found in all cases with versatile coordination modes, while tris complexes were also formed with Fe(II) and Fe(III) ions, revealing the metal binding affinity of the ligand at pH 7.4: Cu(II) > Zn(II) > Fe(II) > Fe(III). The ligand and its Rh(III) complex displayed enhanced cytotoxicity against the resistant MES-SA/Dx5 and Colo320 human cancer cell lines compared to their chemosensitive counterparts. Both organometallic complexes possess high stability in solution, however the Ru(II) complex has lower chloride ion affinity and slower ligand exchange processes, along with the readiness to lose the arene ring that is likely connected to its inactivity.

27 May 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
TPTamás Pivarcsik
Tamás Pivarcsik
GTGábor Tóth
Gábor Tóth
NSNikoletta Szemerédi
Nikoletta Szemerédi
ABAnita Bogdanov
Anita Bogdanov
Gabriella SpenglerGabriella Spengler
Gabriella Spengler
EEEva Anna Enyedy
Eva Anna Enyedy
In this work, the various biological activities of eight organoruthenium(II) complexes were evaluated to reveal correlations with their stability and reactivity in aqueous media. Complexes with general formula [Ru(η6-p-cymene)(X,Y)(Z)] were prepared, where (X,Y) represents either an O,O-ligand (β-diketone), N,O-ligand (8-hydroxyquinoline) or O,S-pyrithione-type ligands (pyrithione = 1-hydroxypyridine-2(1H)-thione) with Cl− or 1,3,5-triaza-7-phosphaadamantane (PTA) as a co-ligand (Z). The tested complexes inhibit the chlamydial growth on HeLa cells, and one of the complexes inhibits the growth of the human herpes simplex virus-2. The chlorido complexes with N,O- and O,S-ligands displayed strong antibacterial activity on Gram-positive strains including the resistant S. aureus (MRSA) and were cytotoxic in adenocarcinoma cell lines. Effect of the structural variation on the biological properties and solution stability was clearly revealed. The decreased bioactivity of the β-diketone complexes can be related to their lower stability in solution. In contrast, the O,S-pyrithione-type complexes are highly stable in solution and the complexation prevents the oxidation of the O,S-ligands. Comparing the binding of PTA and the chlorido co-ligands, it can be concluded that PTA is generally more strongly coordinated to ruthenium, which at the same time decreased the reactivity of complexes with human serum albumin or 1-methylimidazole as well as diminished their bioactivity.

14 February 2024 in Dalton Transactions
Verified
Journal Article
Open access
PDF file
TPTamás Pivarcsik
Tamás Pivarcsik
MKMárton A. Kiss
Márton A. Kiss
URUroš Rapuš
Uroš Rapuš
JKJakob Kljun
Jakob Kljun
Gabriella SpenglerGabriella Spengler
Gabriella Spengler
EEEva Anna Enyedy
Eva Anna Enyedy
Synthesis, characterization, solution speciation, binding affinity towards biomolecules and anticancer activity of organometallic Ru( ii ), Rh( iii ) and Re( i ) complexes of ( N , N ) donor 5α-dihydrotestosterone-based hybrid ligands.